Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 17.36
+0.62 (3.70%)
Mar 6, 2026, 3:59 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.9 billion as of March 6, 2026. Its market cap has increased by 135.64% in one year.
Market Cap
3.90B
Enterprise Value
3.97B
Revenue
351.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.36
Market Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.90B, a decrease of -22.28%. That is a compound annual growth rate of -12.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 3.90B | -7.97% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Luzhu Biotechnology | 4.85B |
| Mirxes Holding Company | 4.49B |
| Shandong Boan Biotechnology | 4.40B |
| Jacobio Pharmaceuticals Group | 4.31B |
| Viva Biotech Holdings | 4.20B |
| TYK Medicines | 3.94B |
| AIM Vaccine | 3.64B |
| Medtide | 3.16B |